DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Rugo HS, Im S-A, Cardoso F. et al.
Phase 3 SOPHIA study of margetuximab + chemotherapy vs. trastuzumab + chemotherapy in patients with HER2+ metastatic breast cancer after prior anti-HER2 therapies: second interim overall survival analysis.

San Antonio Breast Cancer Symposium 2019;
2019: GS1-02

Download Bibliographical Data

Search in: